REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$62,27
0,00%
(0,00) 1D
9 Okt., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$60,78
High
R$62,27
Low
R$60,78
Mkt. cap
78,82 mjd
Avg. vol.
910,00
Volume
32,00
52-wk high
R$73,13
52-wk low
R$49,47
Shares outstanding
101,14 m
No. of employees
15 k
Open
R$60,78
High
R$62,27
Low
R$60,78
Mkt. cap
78,82 mjd
Avg. vol.
910,00
Volume
32,00
52-wk high
R$73,13
52-wk low
R$49,47
Shares outstanding
101,14 m
No. of employees
15 k
News stories
From web sources and news partners
Investing.com Canada
·
4 minute gelede
Regeneron reports sustained efficacy for FOP treatment Pasatru By Investing.com
ad-hoc-news.de
·
2 uur gelede
Regeneron stock stands at EUR 678.75 with P/ E of 18.8
Yahoo Finance
·
3 uur gelede
Greater San Diego Science and Engineering Fair Students Win 8 Awards at the 76th Regeneron International Science and Engineering Fair
ad-hoc-news.de
·
5 uur gelede
RBC raises target for Regeneron stock from USD 737 to USD 810
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15,3 k
Founded1988
HeadquartersTarrytown, New York, Verenigde State van Amerika
Sector-
Websiteregeneron.com